articleBMJApr 14, 2025HYBRID OA

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials

Oxford BioMedica (United Kingdom) · University of Toronto · +52 more institutions

PubMed
Indexed incrossrefdatacitepubmed

Abstract

This is comment on: Hopewell S, et al. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. BMJ. 2025 Apr 14;389:e081124. https://pubmed.ncbi.nlm.nih.gov/40228832 The CONSORT (2025) statement [1] writes about blinding as follows: “Unblinded outcome assessors may differentially assess subjective outcomes, and unblinded data analysts may introduce bias through the choice of analytical strategies, such as the selection of favourable time points or outcomes and by decisions to remove patients from the analyses. These biases have been well documented,” p.27 in [1]. One of the references to this statement, ref. no. 328, is to the trial by Karlowski, Chalmers et al. (1975) [2].…

Citation impact

126
total citations
FWCI
410.99
Percentile
100%
References
500
Citations per year

Authors

39

Topics & keywords

Keywords
  • Elaboration
  • Consolidated Standards of Reporting Trials
  • Guideline
  • Computer science
  • Medicine
  • Alternative medicine
  • Pathology
No related works found for this paper.